Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

PFE still @$35 a year into COVID and with Billions of waiting vaccine customers. Selling the peaks and dips with no real pps appreciation. Too big to succeed? flippers? wow.
At AGN we have some strong prospects IMO. No revenues but a possibility of success for the company to complete their stated agenda of bringing a repurposed drug to Market. Yes most possibly as a buyout item, IMO. Then on to the next. Possible EUA is what I think we are trying to achieve for Ifenprodil, not mass long term production.
Plenty of wine and complaints of missing opportunities in other stocks due to someone else's acumen/flipping/attention/action. BLO and AGN/BTH have had their times and IMO will again.
Another opine is that Excessive Bloviating directed at any opinions and all posts may harm credibility, shooting one's own foot affects the group here.
Yes, lung recovery is the current target as part of a COVID treatment or for CC/IPF or long haulers. Plans for a future after COVID are important for a repurposed drug company...GLTA...
.